Clinical Trials Logo

Filter by:
NCT ID: NCT05195931 Terminated - Clinical trials for Heart Failure, Systolic

Cardiac Output in Heart Failure Patients With Mechanical Pumps

Start date: June 8, 2021
Phase:
Study type: Observational

This study will be looking at how cardiovascular hemodynamics, including cardiac output and flow through a left ventricular assist device (LVADs), change in response to alterations in preload, afterload, and contractility, and also during exercise, in humans with heart failure who are supported by LVADs.

NCT ID: NCT05194839 Terminated - Clinical trials for Palmoplantar Pustulosis

A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Start date: January 5, 2022
Phase: Phase 2
Study type: Interventional

A 12-week Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase 2 Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis followed by an Open-label Extension Phase.

NCT ID: NCT05193318 Terminated - Clinical trials for Major Depressive Disorder

KAP for Depression in Abstinent Opioid Users

KReDO
Start date: January 13, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the study is to examine whether an investigational medication called ketamine along with psychotherapy is an effective treatment for depression in participants with a history of opioid addiction who have not abused opioids in at least 3 months. Participants will receive ketamine through intramuscular injection along with psychotherapy weekly for 8 weeks. Participation for eligible subjects who decide to enroll (including post-medication follow-up visits) will last about 16 weeks or 4 months.

NCT ID: NCT05191862 Terminated - Clinical trials for Intermittent Claudication

Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Start date: April 23, 2022
Phase: Phase 1
Study type: Interventional

The study is designed to evaluate the bioequivalence and the within-subject variability between the test formulation of extended-release tablet of cilostazol (PMR) administered once daily and the reference formulation of immediate-release tablet of cilostazol (Cilostazol) administered twice-daily in normal healthy male and female subjects under fasting conditions.

NCT ID: NCT05191615 Terminated - Motivation Clinical Trials

Workplace Motivation, Job-Satisfaction, and Wellness, Among Nurses and Managers

Start date: January 25, 2022
Phase: N/A
Study type: Interventional

The purpose of this research project is to assess the impact of a multi-level intervention designed to optimize work motivation and support physical and psychological health among employees. The intervention is based on the principles of self-determination theory; an empirically based approach to human motivation that has been applied to work and health and the job demands resources (JD-R) model; an empirically based model of occupational health.

NCT ID: NCT05191472 Terminated - Multiple Myeloma Clinical Trials

Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies

Start date: May 3, 2022
Phase: Phase 2
Study type: Interventional

This phase II trial tests whether pembrolizumab works to shrink tumors in patients with multiple myeloma whose cancer has come back (relapsed) or did not respond to previous treatment (refractory) with anti-BCMA CAR-T therapies. Immunotherapy with pembrolizumab, may induce changes in body's immune system and may interfere with the ability of cancer cells to grow and spread.

NCT ID: NCT05191238 Terminated - IUD Removal Clinical Trials

Intrauterine Device (IUD) Self Removal

Start date: February 22, 2022
Phase: N/A
Study type: Interventional

This pilot research study will teach patients how to self-remove intrauterine contraceptive device (IUD) through an educational video and simulation and evaluate patient perspectives and experiences related to IUD self-removal with two surveys. Patients will be recruited for this study at the time of presentation to the office for IUD removal. After consenting to the procedure, participants will complete a pre-intervention survey, watch a video explaining how to self-remove the IUD, and use two models to simulate IUD removal. After completion of using the models to practice IUD removal, participants will complete a second short survey. The participant will then be given the option of attempting self-removal and be given time to attempt the removal. If the participant elects to have the provider remove their IUD, the provider will do so. At the end of the encounter, participants will fill out a final survey. Research staff will measure the length of the strings of all IUDs prior to routine disposal of the device.

NCT ID: NCT05189977 Terminated - Clinical trials for Post-traumatic Stress Disorder (PTSD)

A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline

Start date: September 7, 2022
Phase: Phase 1
Study type: Interventional

A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline

NCT ID: NCT05185310 Terminated - Atrial Fibrillation Clinical Trials

Strategies in Patients Undergoing Repeat AF Ablation

TRAP-AF
Start date: December 13, 2021
Phase: N/A
Study type: Interventional

The aim of the proposed research project is to compare the efficacy of three different ablation strategies in patients with atrial fibrillation (AF) who are undergoing their first repeat catheter ablation for recurrent AF.

NCT ID: NCT05185037 Terminated - Clinical trials for Movement, Involuntary

NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)

Start date: May 26, 2022
Phase:
Study type: Observational

The study intervention consists of a non-invasive blood pressure (NIBP) measurement device and cuff (FDA-cleared Philips IntelliVue X3 Rev. N.04 patient monitor) running a non-approved modified software containing an enhanced measurement algorithm for NIBP.